California State Teachers Retirement System (CalSTRS)’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.83M Buy
105,563
+19,995
+23% +$893K ﹤0.01% 1159
2025
Q4
$3.98M Buy
85,568
+1,389
+2% +$61.8K ﹤0.01% 1048
2025
Q3
$3.51M Buy
84,179
+8,695
+12% +$278K ﹤0.01% 1103
2025
Q2
$2.17M Buy
75,484
+487
+0.6% +$15K ﹤0.01% 1320
2025
Q1
$2.52M Sell
74,997
-1,267
-2% -$47.3K ﹤0.01% 1215
2024
Q4
$3.9M Buy
76,264
+12,072
+19% +$675K ﹤0.01% 1030
2024
Q3
$3.28M Sell
64,192
-1,344
-2% -$69.3K ﹤0.01% 1122
2024
Q2
$2.94M Buy
65,536
+1,244
+2% +$57.4K ﹤0.01% 1146
2024
Q1
$3.01M Buy
64,292
+6,421
+11% +$251K ﹤0.01% 1165
2023
Q4
$2.06M Sell
57,871
-3,162
-5% -$97K ﹤0.01% 1422
2023
Q3
$1.82M Buy
61,033
+10,097
+20% +$208K ﹤0.01% 1449
2023
Q2
$918K Sell
50,936
-1,720
-3% -$34.3K ﹤0.01% 1972
2023
Q1
$846K Sell
52,656
-1,022
-2% -$18.9K ﹤0.01% 2002
2022
Q4
$982K Buy
53,678
+668
+1% +$11.8K ﹤0.01% 1917
2022
Q3
$1.04M Sell
53,010
-1,328
-2% -$27.1K ﹤0.01% 1864
2022
Q2
$1.01M Buy
54,338
+5,961
+12% +$119K ﹤0.01% 1952
2022
Q1
$1.06M Sell
48,377
-4,015
-8% -$81.3K ﹤0.01% 2002
2021
Q4
$1.49M Buy
52,392
+13,742
+36% +$339K ﹤0.01% 1913
2021
Q3
$814K Sell
38,650
-11,704
-23% -$245K ﹤0.01% 2257
2021
Q2
$949K Buy
50,354
+9,556
+23% +$168K ﹤0.01% 2243
2021
Q1
$623K Hold
40,798
﹤0.01% 2423
2020
Q4
$576K Hold
40,798
﹤0.01% 2351
2020
Q3
$639K Hold
40,798
﹤0.01% 2133
2020
Q2
$715K Buy
40,798
+23,601
+137% +$402K ﹤0.01% 2049
2020
Q1
$253K Buy
17,197
+197
+1% +$4.04K ﹤0.01% 2436
2019
Q4
$427K Hold
17,000
﹤0.01% 2432
2019
Q3
$256K Hold
17,000
﹤0.01% 2681
2019
Q2
$425K Buy
17,000
+3,691
+28% +$91.4K ﹤0.01% 2447
2019
Q1
$303K Buy
13,309
+2,377
+22% +$58.4K ﹤0.01% 2584
2018
Q4
$328K Buy
10,932
+406
+4% +$11.4K ﹤0.01% 2533
2018
Q3
$302K Buy
+10,526
New +$313K ﹤0.01% 2702

Other funds holding CRNX

California State Teachers Retirement System (CalSTRS)'s CRNX Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Crinetics Pharmaceuticals (CRNX) stake by 23% in Q1 2026, buying an estimated $893K and bringing the position to 105,563 shares worth $3.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1159.

California State Teachers Retirement System (CalSTRS) first reported a position in CRNX in Q3 2018 and has held it in 31 quarters since. The position peaked at $3.98M in Q4 2025. 243 funds tracked by Wall St. Rank hold CRNX as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 105,563 shares of Crinetics Pharmaceuticals worth $3.83M as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) bought 19,995 Crinetics Pharmaceuticals shares in Q1 2026, an estimated $893K.
  • Crinetics Pharmaceuticals made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1159 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Crinetics Pharmaceuticals in Q3 2018 and has held it in 31 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Crinetics Pharmaceuticals position peaked at $3.98M in Q4 2025.
  • 243 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.